Catalyst Pharmaceuticals, Inc. (CPRX)
24.69
+0.77
(+3.22%)
USD |
NASDAQ |
Mar 04, 15:31
Catalyst Pharmaceuticals Cash from Investing (TTM) : -0.058M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | -277.78M |
| Rigel Pharmaceuticals, Inc. | -77.92M |
| United Therapeutics Corp. | -551.30M |
| Karyopharm Therapeutics, Inc. | 43.38M |
| Krystal Biotech, Inc. | -58.42M |